Authorization of the first COVID-19 emergency vaccines: The matters arising

Authors

  • Kamoru A. Adedokun Department of Oral Pathology, DUH, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, Tel: +966552442026, E-mail: adeolokun@yahoo.com https://orcid.org/0000-0001-9833-3011
  • Ramat T. Kamorudeen Children Welfare Unit, Osun State Hospital Management Board, Asubiaro, Osogbo, Osun State, Nigeria; Department of Public Health, University of South Wales, UK https://orcid.org/0000-0003-2434-349X
  • Ibrahim O. Bello Department of Medical Laboratory Science, Nigerian Navy School of Health Sciences, Offa, Kwara State, Nigeria https://orcid.org/0000-0002-6292-5012

DOI:

https://doi.org/10.17179/excli2021-3384

Keywords:

COVID-19, emergency vaccine, Moderna, Pfizer/BioNTech, mutation, SARS-CoV-2

Author Biographies

Kamoru A. Adedokun, Department of Oral Pathology, DUH, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, Tel: +966552442026, E-mail: adeolokun@yahoo.com

Mr ADEDOKUN K. Ademola is a graduate of Medical Laboratory Science with Second Class Upper Division. He also holds Higher National Diploma (HND) in Microbiology and Master of Science (M.Sc.) Degree in Chemical Pathology, all from reputable institutions in Nigeria. He obtained certificates in different areas of epidemiology, mostly from USAID (in collaboration with John Hopkins Bloomberg School of Public Health, USA).
He is a member/registered professional of many reputable societies/health councils such as Association of Medical Laboratory Science Council of Nigeria (MLSCN); Saudi Commission for Health Specialties (SCFHS), Australasian Immunohistochemistry Society (AIS), Australia, among others.
He is a Medical Scientist with great passion and drive for laboratory medicine. His future aspirations involve research and teaching molecular oncology. He has worked in different clinical settings ranging from government to private organizations and equally both at national and international levels

Ramat T. Kamorudeen, Children Welfare Unit, Osun State Hospital Management Board, Asubiaro, Osogbo, Osun State, Nigeria; Department of Public Health, University of South Wales, UK

ramattoyin243@gmail.com (funktioniert nicht), obige email aus dem Internet in einer seiner Publikationen genommen und versandt.

Downloads

Published

2021-03-15

How to Cite

Adedokun, K. A., Kamorudeen, R. T., & Bello, I. O. (2021). Authorization of the first COVID-19 emergency vaccines: The matters arising. EXCLI Journal, 20, 655–660. https://doi.org/10.17179/excli2021-3384

Issue

Vol. 20 (2021)

Section

Letters to the editor

License

Copyright (c) 2021 Kamoru A. Adedokun, Ramad T. Kamorudeen, Ibrahim O. Bello

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).